{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452675503321"]
[null,null,"Titolo",null,"Magnetic nanoparticles [[electronic resource] ] : properties, synthesis and applications / / Beate Acklin and Edon Lautens, editors"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Science Publishers, c2012"]
[null,null,"ISBN",null,"1-61942-445-2"]
[null,null,"Descrizione fisica",null,"1 online resource (336 p.)"]
[null,null,"Collana",null,"Nanotechnology science and technology"]
[{"$nulls":4},"Physics research and technology"]
[null,null,"Disciplina",null,"620.1/15"]
[null,null,"Soggetti",null,"Nanoparticles - Magnetic properties"]
[{"$nulls":4},"Nanostructures - Magnetic properties"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"MAGNETIC NANOPARTICLES \"\"; \"\"MAGNETIC NANOPARTICLES \"\"; \"\"CONTENTS\"\"; \"\"PREFACE \"\"; \"\"FORMULATIONS FOR LOCAL,  MAGNETICALLY MEDIATED HYPERTHERMIA  TREATMENT OF SOLID TUMORS \"\"; \"\"ABSTRACT \"\"; \"\"1. INTRODUCTION: UNDERSTANDING THE  COMPLEXITY OF HYPERTHERMIA \"\"; \"\"1.1. Biological and Clinical Rationale for Induced Hyperthermia \"\"; \"\"1.1.1. Heat Effects and Toxicity at Cellular Level\"\"; \"\"Morphostructural Changes Induced by Heat \"\"; \"\"Metabolic Effects of Heat \"\"; \"\"Heat Cytotoxicity and Thermal Dosimetry \"\"; \"\"Molecular Biology of Stress Responses: Heat Shock, Hypoxia and Connections \"\""]
[{"$nulls":4},"\"\"1.2.1. Hyperthermia in Oncology \"\"\"\"Hyperthermia Treatment Modalities \"\"; \"\"Hyperthermia and Solid Tumor Pathophysiology\"\"; \"\"Hyperthermic Therapy Combinations, Emphasis on Embolization Procedures \"\"; \"\"Hyperthermia and Immunological Considerations \"\"; \"\"1.2. Current Technical Status of Induced Hyperthermia \"\"; \"\"1.2.1. Physical Modalities for Induced Hyperthermia \"\"; \"\"1.2.2. Inductive Modalities \"\"; \"\"1.2.3. Magnetic Losses \"\"; \"\"Hysteresis Losses \"\"; \"\"Losses by Magnetic Relaxations \"\"; \"\"2. FORMULATIONS FOR LOCAL HYPERTHERMIA TREATMENT  OF HARD TISSUE TUMORS \"\""]
[{"$nulls":4},"\"\"2.1. Magnetic Ceramic, Glass and Glass-Ceramic Materials \"\"\"\"2.2. Glass/Ceramic Particles and Microspheres\"\"; \"\"2.3. Magnetic Materials for Cementoplasty\"\"; \"\"3. FORMULATIONS AND MINIMALLY INVASIVE PROCEDURES FOR MAGNETICALLY MEDIATED LOCAL HYPERTHERMIA "]
[{"$nulls":4},"TREATMENT OF SOFT TISSUE TUMORS  \"\"; \"\"3.1. Arterial Injections and Arterial Embolization Hyperthermia (AEH) \"\"; \"\"3.1.1. Microparticles \"\"; \"\"3.1.2. Formulation Forming-Depot \"\"; \"\"3.2. Intratumoral Direct Injection Hyperthermia (DIH)\"\"; \"\"3.2.1. Formulation Forming Depot \"\"; \"\"3.2.2. Formulations Forming Implants In Situ \"\""]
[{"$nulls":4},"\"\"4. MAGNETIC LIPOSOMES AND LOCAL HYPERTHERMIA  TREATMENT OF TUMORS \"\"\"\"4.1. General Characteristics of Liposomes \"\"; \"\"4.2. Magnetoliposomes and Magnetically Induced Local  Hyperthermia of Tumor\"\"; \"\"4.3. Immunoconjugated Magnetoliposomes for the Systemic Approach of Magnetically Mediated Hyperthermia of  Solid Tumors \"\"; \"\"4.3.1. Magnetoliposomes Conjugated with Anti CA9 (Human MN) Antigen Antibodies \"\"; \"\"4.3.2. Magnetoliposomes Coupled with Anti-HER2 Antibodies \"\"; \"\"Anti-HER2 Immunoconjugated Magnetoliposomes and Pharmaceutical Considerations Associated with Anti-HER2 Antibodies\"\""]
[{"$nulls":4},"\"\"Anti-HER2 Immunoconjugated Magnetoliposomes and Micropharmacology Considerations Associated with Non Magnetic Anti-HER2 Immunoliposomes\"\"\"\"4.4. Cationic Magnetoliposomes in Bone Metastasis of Prostate Cancer Model \"\"; \"\"4.5. Neutral Magnetoliposomes: Targeting Draining Lymphatic Nodes for Magnetic Hyperthermia \"\"; \"\"CONCLUSION \"\"; \"\"ACKNOWLEDGMENTS \"\"; \"\"6. LIST OF ABBREVIATIONS, UNITS, NOTATIONS AND SYMBOLS\"\"; \"\"REFERENCES \"\"; \"\"ORGANIC BASED MAGNETIC NANOPARTICLES-POLYMERS AND VARIOUS CALIXARENE BASED MAGNETIC NANOPARTICLES \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION\"\""]
[{"$nulls":4},"\"\"1. MAGNETIC NANOPARTICLE- POLYMERS  \"\""]